MEDP eps in a glimpse
Analyst Rating Consensus
5
Ratings
MEDP Price Target
Highest Price Target
$469.00
29.81% Upside
)Mean Price Target
$420.20
16.31% Upside
)Lowest Price Target
$336.00
-7% Downside
)MEDP Price Target History
Actual EPS vs Estimated EPS
How EPS can be helpful
Understanding the true essence of Earnings Per Share (EPS) for a company can be a complex endeavor. EPS, essentially a measure of a company's profitability on a per-share basis, is often used by investors as a barometer of financial health. However, it's crucial to recognize that EPS can be subject to manipulation through various accounting techniques and management strategies.
MEDP Earnings History
Frequently Asked Questions
Brokerage firms have given MEDP stock an average recommendation of Strong Buy. 5 analysts have given their ratings to MEDP out of which 2 analysts have given strong buy call, 2 analysts have given buy call, 1 analysts rate it hold, 0 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of $420.20 gives the stock implied upside of roughly 16.31% over the next year or so.
Analysts suggest MEDP's stock price would rise to a high of $469.00.
Within the next 12 months, analysts predict the MEDP stock price could move to $336.00.
MEDP stock has an average analyst estimate of $420.20.
MEDP shares are currently trading 16.31% above this price target.
Its quarterly earnings per share (EPS) came in at $2.75 versus consensus estimates of $2.52, and above the comparable year-ago quarter’s EPS of $1.93.
MEDP's forecasts by analysts estimating quarterly EPS at $2.79 and $15.94 for the whole year.
The analysts have projected 16.52% EPS growth for MEDP in the next five years, compared to growth rates of 35.06% in the past five years.